<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ariën, Kevin K</style></author></authors><tertiary-authors><author><style face="normal" font="default" size="100%">Heyndrickx, Leo</style></author><author><style face="normal" font="default" size="100%">Johan Michiels</style></author><author><style face="normal" font="default" size="100%">Katleen Vereecken</style></author><author><style face="normal" font="default" size="100%">Sandra Coppens</style></author><author><style face="normal" font="default" size="100%">Betty Willems</style></author><author><style face="normal" font="default" size="100%">Koen Bartholomeeusen</style></author></tertiary-authors><subsidiary-authors><author><style face="normal" font="default" size="100%">Kurt Van Lent</style></author><author><style face="normal" font="default" size="100%">Pieter Pannus</style></author><author><style face="normal" font="default" size="100%">Geert A Martens</style></author><author><style face="normal" font="default" size="100%">Van Esbroeck, Marjan</style></author><author><style face="normal" font="default" size="100%">Maria Goossens</style></author><author><style face="normal" font="default" size="100%">Arnaud Marchant</style></author><author><style face="normal" font="default" size="100%">I Desombere</style></author></subsidiary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.</style></title><secondary-title><style face="normal" font="default" size="100%">NPJ Vaccines</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2022 Mar 08</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue></record></records></xml>